StockTipsArenaBeta

BUY Sudarshan Pharma Industries Limited — Mahesh Ojha, Kantilal Chhaganlal Securities

BUYSudarshan Pharma Industries Limited
Sudarshan Pharma Industries share price target & all analyst calls

byMahesh Ojha, Kantilal Chhaganlal SecuritiesHorizon: NA (inferred 1–3 months)30 Oct 2026via LiveMint Markets

Entry₹37Stated
Target₹42
Total upside +13.51%
Stop loss₹31.8-14.05% risk
CMP₹36.425h ago
Active-1.57%+15.32%upside left 3 mo left
Follow Mahesh Ojha for new callsGet alertsWatch SUDARSHAN for new buy/sell callsGet alertsSee 1 other Short-term call on SUDARSHANSee 74 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Oct, 9:22 pm IST
2 supporting1 opposing
Supports the BUY call (2)

The board approved raising up to Rs 72 crores through the issuance of convertible warrants to promoters on a preferential basis.

NSE · Issue of Securities·30 Oct · today

(opens in new tab)

Small-cap stock under ₹50 jumps 7% despite weak trends on Dalal Street; here's why | Target price, stop-loss

NewsLivemint·28 Oct · 2d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·30 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sudarshan Pharma Industries

All analyst calls on Sudarshan Pharma Industries

More from Mahesh Ojha, Kantilal Chhaganlal Securities

Every call and its outcome